The viability of ovarian carcinoma cells A2780 affected by titanium dioxide nanoparticles and low ultrasound intensity

English version České info

The effect of titanium dioxide nanoparticles and ultrasound was studied on human ovarian carcinoma cells A2780 in vitro. The viability of cells has been studied by a standard 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide viability assay in different modes of treatment: application of nanoparticles alone, exposure to ultrasound field alone, application of nanoparticles followed by an exposure to ultrasound, and an exposure to ultrasound followed by addition of nanoparticles. The viability was measured 48 and 72 hours after the exposure. The titanium dioxide nanoparticles used were smaller than 100 nm in diameter, ultrasound was applied at a therapeutical intensity of 1 W∙cm^-2 and frequency of 1 MHz; the cells were treated in a 37 °C thermostated water bath in a configuration with far field ultrasound exposure. The final concentration of titanium dioxide nanoparticles was 50 μg/mL. The results showed that a combined effect of titanium dioxide nanoparticles and ultrasound influenced the viability of human carcinoma cells more than the application of titanium dioxide nanoparticles or ultrasound alone.The outcomes showed a significant difference between experimental groups with different sequences of application or exposure of nanoparticles or ultrasound. Maximal decrease of viability was achieved by application of experimental protocol with exposure to ultrasound first, followed by application of nanoparticles. It seems to indicate the possibility to intensify the effect of nanoparticles on cell viability by previous ultrasound exposure.

Keywords:
nanomaterials, titanium dioxide, ultrasound, viability

Autoři: Vladan Bernard; Vojtěch Mornstein
Působiště autorů: Masaryk University, Faculty of Medicine, Department of Biophysics, Brno, Czech Republic
Vyšlo v časopise: Lékař a technika - Clinician and Technology No. 1, 2016, 46, 21-24
Kategorie: Původní práce

Souhrn

Keywords:
nanomaterials, titanium dioxide, ultrasound, viability

Zdroje

[1] Ozols, R.F., Bookman, M.A., Connolly, D.C., Daly, M.B., Godwin, A.K., Schilder, R.J., Xu, X., Hamilton, T.C. Focus on epithelial ovarian cancer. Cancer Cell, 2004, 5, 19-24.

[2] Parida, S., Das. T.K. Nanotechnology and cancer. Apollo Medicine, 2008, 5, 251-2.

[3] Thomas, D.G., Pappu, R.V., Baker, N.A. NanoParticle Ontology for cancer nanotechnology research. Journal of Biomedical Informatics, 2011, 44, 59-74.

[4] Fukumori, Y., Ichikawa. H. Nanoparticles for cancer therapy and diagnosis. Advanced Powder Technol., 2006, 17, 1–28.

[5] Lanone, S., Rogerieux, F., Geys, J., Dupont, A., Maillot-Marechal, E., Boczkowski, J., Lacroix G., Hoet, P. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Particle and Fibre Toxicology, 2009, 6, 14.

[6] Kubota, Y., Shuin, T., Kawasaki, C., Hosaka, M., Kitamura, H., Cai, R., Sakai, H., Hashimoto, K., Fujishima, A. Photokilling of T-24 human bladder cancer cells with titanium dioxide. Br J Cancer, 1994, 70 1107-1111.

[7] Liu, L., Miao, P., Xu, Y., Tian, Z., Zou, Z., Li, G. Study of Pt/TiO2 nanocomposite for cancer-cell treatment. Journal Photochem Photobio B., 2010, 98, 207-210.

[8] Nakata, K., Ochiai, T., Murakami, T., Fujishima, A. Photoenergy conversion with TiO2 photocatalysis: New materials and recent applications. Electrochim Acta, 2012, 84, 103–111.

[9] Bernard, V., Škorpíková, J., Mornstein, V. The combined effect of ultrasound exposure and cisplatin on human ovarian carcinoma cells A2780. Folia Biol.- Prague, 2008, 54, 97-101.

[10] Bernard, V., Mornstein, V., Bourek, A. Effect of near field ultrasound on carboplatin treatment of ovarian carcinoma cells. Indian J Biochem Bio, 2013, 50, 284-288.

[11] Rosenthal, I., Sostaric, J.Z., Riesz, P. Sonodynamic therapy-a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem, 2004, 11, 349-363.

[12] Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 16, 55-63.

[13] Harada, Y., Ogawa, K., Irie, Y., Endo, H., Feril Jr., L.B., Uemura, T., Tachibana, K. Ultrasound activation of TiO2 in melanoma tumors. J Control Release, 2011, 149, 190-195.

[14] ]Mihranyan, A., Ferraz, N.,Strømme M. Current status and future prospects of nanotechnology in cosmetics. Prog Mater Science, 2012, 57, 875–910.

[15] Blasco, C., Picó, Y. Determining nanomaterials in food. Trends in Analytical Chemistry, 2011, 30, 84-99.